Covid-19 neurology update: 20th April 2020

Information continues to accrue on the potential neurological effects of infection with SARS-Cov-2, the virus that causes Covid-19. In the last few days, three papers have appeared detailing cases of acute inflammatory neuropathies associated with Covid-19. A paper in the New England Journal of Medicine presents five Italian patients with Guillain-Barré syndrome (GBS),(1) a condition … Read more

Neurological consequences of Covid-19

There is as yet very little in the published literature on the neurological consequences of Covid-19 (the disease caused by infection with SARS-Cov-2). The first extensive report – a retrospective consecutive case series of 214 patients from Wuhan, China, with either moderate or severe COVID-19, was published in JAMA Neurology in early April 2020.(1) Of … Read more

LHC – Covid-19 update

Following the Government’s advice today to avoid all “non-essential” travel, I have made the decision to conduct all London Headache Centre consultations remotely until further notice. I will be very happy to review new and old patients via telephone, Skype, or other video conferencing methods. Consultation slots will continue to be available by contacting The … Read more

My disclosures 2019

I am employed by Buckinghamshire Healthcare NHS Trust for 10.5 PA (42 hours) per week. In addition to that I am engaged in private practice at BMI The Chiltern Hospital and The Medical Chambers Kensington. I have received honoraria in the last 10 years for advisory boards and lecturing from Novartis, TEVA Pharmaceuticals, Lilly, and … Read more